0001860742 false Bausch & Lomb Corp 0001860742 2023-06-01 2023-06-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

____________________________

 

FORM 8-K

 

____________________________

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

June 1, 2023

Date of Report (Date of the earliest event reported)

 

____________________________

 

Bausch + Lomb Corporation

(Exact Name of Registrant as Specified in Its Charter)

 

____________________________

 

         
Canada   001-41380   98-1613662

(State or Other Jurisdiction of

Incorporation or Organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

520 Applewood Crescent

Vaughan, Ontario

Canada L4K 4B4

(Address of Principal Executive Offices)(Zip Code)

 

(905) 695-7700

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

         
Title of each class  

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Shares   BLCO   New York Stock Exchange, Toronto Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On June 1, 2023, Bausch + Lomb Corporation (the “Company”) announced that, in connection with the reshaping of the Company’s executive leadership team, Joseph F. Gordon will transition from his current role as President, Global Consumer, Surgical and Vision Care to the new role of strategic advisor to the Chairman and Chief Executive Officer of the Company, effective June 1, 2023. Mr. Gordon will remain subject to the existing terms and conditions of his employment agreement with the Company, dated August 2, 2018 (as amended), as filed as Exhibits 10.18 and 10.19 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as filed with the Securities and Exchange Commission on February 22, 2023.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

   

Exhibit

Number

Description
   
99.1 Press Release dated June 1, 2023
   
104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

     
BAUSCH + LOMB CORPORATION  
     
By:

/s/ Brenton L. Saunders

 
Name: Brenton L. Saunders  
Title: Chairman and Chief Executive Officer  

 

Date: June 1, 2023